A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome

Annals of Clinical and Laboratory Science

Volumn 42, Issue 3, 2012, Pages 271-280

  Chung, Jae Woo ^a   Park, Chan Jeoung ^a   Cha, Choong Hwan ^a   Cho, Young Uk ^a   Jang, Seongsoo ^a   Chi, Hyun Sook ^a   Seo, Eul Ju ^a   Lee, Jung Hee ^a   Lee, Je Hwan ^a   Lee, Kyoo Hyung ^a   Im, Ho Joon ^a   Seo, Jong Jin ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Flow cytometry; Grunulocytic panel; Immunophenotypic abnormalities; Multiparameter; Myelodysplastic syndrome

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD33 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD64 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOPSY, NEEDLE; BONE MARROW; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; MYELODYSPLASTIC SYNDROMES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84868662852     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Loken MR, van de Loosdrecht A, Ogata K, Orfao A, Wells DA. Flow cytometry in myelodysplastic syndromes: report from a working conference. Leuk Res 2008;32:5-17.
2. Kussick SJ, Fromm JR, Rossini A, Li Y, Chang A, Norwood TH, Wood BL. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol 2005;124:170-181.
3. Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 2005;19:776-783.
4. Pagnucco G, Giambanco C, Gervasi F. The role of flow cytometric immunophenotyping in myelodysplastic syndromes. Ann N Y Acad Sci 2006;1089:383-394.
5. Stetler-Stevenson M, Yuan CM. Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis. Int J Lab Hematol 2009;31:479-483.
6. Elghetany MT. Surface marker abnormalities in myelodysplastic syndromes. Haematologica 1998;83:1104-1115.
7. Huang M, Li J, Zhao G, Sui X, Zhao X, Xu H. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry. Int J Lab Hematol 2010;32:275-281.
8. van de Loosdrecht AA, Alhan C, Bene MC, Della Porta MG, Drager AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, Ireland R, Jansen JH, Kern W, Malcovati L, Te Marvelde JG, Mufti GJ, Ogata K, Orfao A, Ossenkoppele GJ, Porwit A, Preijers FW, Richards SJ, Schuurhuis GJ, Subira D, Valent P, van der Velden VH, Vyas P, Westra AH, de Witte TM, Wells DA, Loken MR, Westers TM. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 2009;94:1124-1134.
9. Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98:979-987.
10. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman J. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France, International Agency for Research on Cancer (IARC), 2008.
11. Cazzola M. Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome. Haematologica 2009;94:1041-1043.
12. Goardon N, Nikolousis E, Sternberg A, Chu WK, Craddock C, Richardson P, Benson R, Drayson M, Standen G, Vyas P, Freeman S. Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes. Haematologica 2009;94:1160-1163.
13. Moon HW, Huh JW, Lee M, Hong KS, Chung WS. Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes. Korean J Lab Med 2010;30:97-104.
14. Ogata K, Della Porta MG, Malcovati L, Picone C, Yokose N, Matsuda A, Yamashita T, Tamura H, Tsukada J, Dan K. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. Haematologica 2009;94:1066-1074.
15. van de Loosdrecht AA, Westers TM, Ossenkoppele GJ. Flow cytometry in myelodysplastic syndromes: towards a new paradigm in diagnosis and prognostication? Leuk Res 2008;32:205-207.
16. Xu D, Schultz C, Akker Y, Cannizzaro L, Ramesh KH, Du J, Ratech H. Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia. Am J Hematol 2003;74:9-16.
17. Lorand-Metze I, Ribeiro E, Lima CS, Batista LS, Metze K. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leuk Res 2007;31:147-155.
18. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102:394-403.